Biolab Sanus Farmaceutica   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Sao Paulo Brazil (1978)
Status: No NME R&D (1978)

Organization Overview

First Clinical Trial
2009
NCT00986570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Biolab Sanus Farmaceutica